DrugCite
Search

LEXOTAN

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Lexotan Adverse Events Reported to the FDA Over Time

How are Lexotan adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Lexotan, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Lexotan is flagged as the suspect drug causing the adverse event.

Most Common Lexotan Adverse Events Reported to the FDA

What are the most common Lexotan adverse events reported to the FDA?

Suicide Attempt
35 (3.52%)
Overdose
23 (2.31%)
Intentional Overdose
19 (1.91%)
Somnolence
19 (1.91%)
Drug Exposure During Pregnancy
15 (1.51%)
Loss Of Consciousness
15 (1.51%)
Neuroleptic Malignant Syndrome
14 (1.41%)
Sopor
14 (1.41%)
Drug Withdrawal Syndrome Neonatal
13 (1.31%)
Depressed Level Of Consciousness
12 (1.21%)
Multiple Drug Overdose Intentional
12 (1.21%)
Show More Show More
Self Injurious Behaviour
12 (1.21%)
Drug Toxicity
11 (1.11%)
Irritability
11 (1.11%)
Bradyphrenia
10 (1.01%)
Insomnia
10 (1.01%)
Pyrexia
10 (1.01%)
Vomiting
10 (1.01%)
Anxiety
9 (.91%)
Aspartate Aminotransferase Increase...
9 (.91%)
Convulsion
9 (.91%)
Multiple Drug Overdose
9 (.91%)
Bradykinesia
8 (.8%)
Drug Interaction
8 (.8%)
Heart Rate Increased
8 (.8%)
Hepatic Function Abnormal
8 (.8%)
Hypotension
8 (.8%)
Pancreatitis Acute
8 (.8%)
Renal Failure Acute
8 (.8%)
Altered State Of Consciousness
7 (.7%)
Blood Creatine Phosphokinase Increa...
7 (.7%)
Blood Pressure Decreased
7 (.7%)
Coma
7 (.7%)
Diabetic Ketoacidosis
7 (.7%)
Drug Ineffective
7 (.7%)
Dyskinesia
7 (.7%)
Fall
7 (.7%)
Alanine Aminotransferase Increased
6 (.6%)
Constipation
6 (.6%)
Dizziness
6 (.6%)
Hyponatraemia
6 (.6%)
Nausea
6 (.6%)
White Blood Cell Count Increased
6 (.6%)
Aggression
5 (.5%)
Drug Withdrawal Syndrome
5 (.5%)
Neonatal Respiratory Depression
5 (.5%)
Rhabdomyolysis
5 (.5%)
Asthenia
4 (.4%)
Blood Lactate Dehydrogenase Increas...
4 (.4%)
Completed Suicide
4 (.4%)
Dry Mouth
4 (.4%)
Dyspepsia
4 (.4%)
Oedema Peripheral
4 (.4%)
Platelet Count Decreased
4 (.4%)
Pneumonia
4 (.4%)
Renal Impairment
4 (.4%)
Respiratory Disorder Neonatal
4 (.4%)
Serotonin Syndrome
4 (.4%)
Speech Disorder
4 (.4%)
Tachypnoea
4 (.4%)
Agitation
3 (.3%)
Alcohol Abuse
3 (.3%)
Apnoea
3 (.3%)
Blood Chloride Decreased
3 (.3%)
Blood Creatinine Increased
3 (.3%)
Blood Glucose Increased
3 (.3%)
Caesarean Section
3 (.3%)
Condition Aggravated
3 (.3%)
Decreased Appetite
3 (.3%)
Depression
3 (.3%)
Developmental Delay
3 (.3%)
Drug Abuse
3 (.3%)
Drug Administration Error
3 (.3%)
Drug Exposure Via Breast Milk
3 (.3%)
Drug Level Increased
3 (.3%)
Dry Eye
3 (.3%)
Epilepsy
3 (.3%)
Erythema
3 (.3%)
Face Oedema
3 (.3%)
Feeding Disorder Neonatal
3 (.3%)
Feeling Jittery
3 (.3%)
Gait Disturbance
3 (.3%)
Gamma-glutamyltransferase Increased
3 (.3%)
Head Injury
3 (.3%)
Headache
3 (.3%)
Homicide
3 (.3%)
Hypoaesthesia
3 (.3%)
Hypocalcaemia
3 (.3%)
Hypotonia
3 (.3%)
Hypoventilation Neonatal
3 (.3%)
Impulsive Behaviour
3 (.3%)
Japan Coma Scale Abnormal
3 (.3%)
Malaise
3 (.3%)
Moaning
3 (.3%)
Myoclonus
3 (.3%)
Neonatal Disorder
3 (.3%)
Osteoporosis
3 (.3%)
Oxygen Saturation Decreased
3 (.3%)
Pain In Extremity
3 (.3%)
Pleural Effusion
3 (.3%)
Pneumonia Aspiration
3 (.3%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Lexotan, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Lexotan is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Lexotan

What are the most common Lexotan adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Lexotan, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Lexotan is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Lexotan According to Those Reporting Adverse Events

Why are people taking Lexotan, according to those reporting adverse events to the FDA?

Anxiety
120
Depression
119
Product Used For Unknown Indication
55
Insomnia
47
Drug Use For Unknown Indication
39
Sleep Disorder
29
Show More Show More
Schizophrenia
21
Panic Disorder
13
Prophylaxis
11
Agitation
10
Sleep Disorder Therapy
8
Bipolar I Disorder
8
Neurosis
7
Sedation
7
Suicide Attempt
7
Muscle Relaxant Therapy
6
Anxiety Disorder
6
Nervousness
6
Analgesic Therapy
5
Self Injurious Behaviour
4
Sedative Therapy
4
Bipolar Disorder
4
Antidepressant Therapy
4
Psychosomatic Disease
4
Ill-defined Disorder
4
Panic Attack
4
Stress
3
Alcoholism
3
Drug Exposure During Pregnancy
3
Anxiolytic Therapy
3
Tachycardia
3
Irritability
3
Obsessive-compulsive Disorder
3
Blood Pressure
3
Borderline Personality Disorder
3
Hypertension
2
Muscle Tightness
2
Cardiac Failure
2
Relaxation Therapy
2
Nervous System Disorder
2
Epilepsy
2
Intentional Overdose
2
Convulsion
2
Hypochondriasis
2
Blood Pressure Increased
1
Senile Dementia
1
Dementia Alzheimers Type
1
Paranoia
1
Overdose
1
Central Pain Syndrome
1
Restlessness
1

Lexotan Case Reports

What Lexotan safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Lexotan. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Lexotan.